Milkhaus Laboratory Report issue

For profit Phase 2
Founded: Providence RI United States (1993)
Status: Defunct (2004)

Organization Overview

First Clinical Trial
2002
NCT00044226
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

ml-04a (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperplasia (Phase 2)

Prostatic Hyperplasia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1